BioSpace News Archive

Moleculin Biotech, Inc. today announced that the first two patients have been enrolled in its European clinical trial of WP1220 for the topical treatment of cutaneous T-cell lymphoma (CTCL).

Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ: NVCN)(TSX: NVCN), today announced that data on the Neovasc Reducer™ (“Reducer”) was featured in session 725, titled, “Refractory Angina: Options for Patients With “No Options""

Nebraska Total Care, in conjunction with Gov. Pete Ricketts’ declared state of emergency, is available to provide assistance to our members across the state of Nebraska affected by flooding.

Leading Peer-Reviewed Dermatology Journal Features Phase 2 Data

ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics targeting toxic oligomers implicated in the development of neurodegenerative diseases, will present data for new antibody candidates that show stringent selectivity for the toxic forms of alpha-synuclein, considered a root cause of Parkinson’s disease

Veracyte, Inc. (Nasdaq: VCYT), a leading genomics diagnostics company, today announced its “Summit” level sponsorship of the Climb to Fight Cancer’s Team Kilimanjaro expedition as part of the company’s expanded efforts to combat this disease.

Former Health and Human Services Secretary brings government and health care expertise to company working to detect cancer earlier

Nova Medical Centers, one of the nation’s top occupational medicine providers, is pleased to announce its Humble location is relocating to a brand new, state-of-the-art facility.

Strata OncologyTM, a leading precision oncology company, today announced the launch of version 3.0 of StrataNGSTM, its pan-cancer assay for solid tumors.

Envirotainer, the global market leader in secure cold chain solutions for air transport of pharmaceuticals, announced that they are expanding their network of stations supporting their state-of-the-art e-technology containers, namely the RKN e1 and RAP e2, by adding Mumbai, India, to the list.